MBX Biosciences MBX
$49.55 −$3.86 (-7.23%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $49.55 0.00%
Open$53.48
Prev close$53.41
Day range$49.36 – $54.43
Volume581.9K
Market cap$2.46B
P/E (TTM)–
Dividend yield–
MBX Stock News
Headlines matching MBX Biosciences or the MBX ticker, most recent first.
- MBX Biosciences, Inc. (MBX) Gets a Buy From Mizuho Securities
- Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $91
- LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $121
- Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
- Barclays Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $88 Positive
- LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $121 Positive
- 4: MBX Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Hoerter Steven L.
- MBX Biosciences Insiders Added US$1.06m Of Stock To Their Holdings
- J.P. Morgan Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $88
- Stifel Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $70 Positive
- Analysts Offer Insights on NA Companies: MBX Biosciences, Inc. (MBX), Septerna, Inc. (SEPN) and Six Flags Entertainment Corporation (FUN)
- Truist Financial Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $88
- Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $91 Positive
- UBS Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $90
- Truist Financial Maintains MBX Biosciences(MBX.US) With Buy Rating
No comments yet — be the first to weigh in on MBX.
Sign in to join the discussion.